Literature DB >> 21725058

Inhaled nitric oxide and bronchopulmonary dysplasia.

Robin H Steinhorn, Philip W Shaul, Raye-Ann O deRegnier, Kathleen A Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21725058     DOI： 10.1542/peds.2011-1270A

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  4 in total

Review 1.  Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

Review 2.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

3.  Diagnosis and treatment of pulmonary hypertension in infancy.

Authors:  Robin H Steinhorn
Journal:  Early Hum Dev       Date:  2013-09-29       Impact factor: 2.079

Review 4.  Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?

Authors:  Thomas M Raffay; Richard J Martin; James D Reynolds
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.